$JAN

Janus Living, Inc.

No enriched coverage for $JAN in the last 7 days.

No SEC Form 4 filings for $JAN in the last 30 days.

See all $JAN insider activity →

Healthpeak (DOC) Turns Portfolio Sales Into Fatter 2026 Guidance

Healthpeak Properties (DOC) raised its 2026 guidance, citing strong performance in outpatient medical and lab leasing, and significant growth at its senior housing operator, Janus Living (JAN). The company reported $0.46 FFO per share, flat year-over-year, and used asset sales to reduce debt and fund buybacks. Lab segment NOI declined, and leverage remains at 4.7x EBITDAre.

Janus Living, Inc. (JAN): Entry into a Material Definitive Agreement

Janus Living, Inc. (JAN) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Agreement Credit Facility Amendment On March 23, 2026, Janus Living, Inc. (the “Company”) and Janus Living OP, LLC (the “Operating Company”) entered into a Credit Agreement (the “Original Credit Agreement”), dated as of March 23, 2026, by and among

JAN sentiment & insider activity

Recent JAN coverage spans corporate actions, earnings and market movers.

What's driving JAN

AlphAI scores every news story that mentions JAN with an AI model for sentiment and relevance, and aggregates insider trades from Janus Living, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $JAN

Score

Senior Living Dealbook: Priority Life Care Acquires Seven Communities; Janus Living Increases Credit to $1.25B

Priority Life Care and Almanac acquired seven senior living communities in Pennsylvania. Janus Living (JAN) secured a $1.25B credit facility. ESI sold a four-property portfolio for $200M. Walker & Dunlop closed $30M in LIHTC for a Texas affordable senior housing project. Embrace Living expanded by managing Brementowne Manor Senior Apartments.

$DOCMedAI 8/10

Healthpeak (DOC) Turns Portfolio Sales Into Fatter 2026 Guidance

Healthpeak Properties (DOC) raised its 2026 guidance, citing strong performance in outpatient medical and lab leasing, and significant growth at its senior housing operator, Janus Living (JAN). The company reported $0.46 FFO per share, flat year-over-year, and used asset sales to reduce debt and fund buybacks. Lab segment NOI declined, and leverage remains at 4.7x EBITDAre.

$JANHigh

Janus Living, Inc. (JAN): Entry into a Material Definitive Agreement

Janus Living, Inc. (JAN) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Agreement Credit Facility Amendment On March 23, 2026, Janus Living, Inc. (the “Company”) and Janus Living OP, LLC (the “Operating Company”) entered into a Credit Agreement (the “Original Credit Agreement”), dated as of March 23, 2026, by and among

$JANMed

Janus Living, Inc. (JAN): Entry into a Material Definitive Agreement

Janus Living, Inc. (JAN) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Agreement On August 12, 2026, Janus Living, Inc. (the “Company” and, unless the context otherwise requires, together with its consolidated subsidiaries, “we,” “us,” or “our”) closed its registered underwritten public offering (the “Offering”) of 18

$JANMedAI 8/10

Why is Janus Living stock sliding today?

Janus Living (JAN) shares fell 2.6% in pre-open after the company priced a follow-on offering of 16 million Class A-1 shares at $29.00, below the prior close of $30.18. Underwriters received a 30-day option for up to 2.4 million more shares. Proceeds will fund acquisitions and general purposes, with expected closing Aug. 13, 2026.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

Janus Living Reports Second Quarter 2026 Results and Increases Full Year 2026 Guidance

Janus Living, Inc. (JAN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Janus Living Reports Second Quarter 2026 Results and Increases Full Year 2026 Guidance DENVER, August 4, 2026 - Janus Living, Inc. (NYSE : JAN) (“Janus Living”), a pure-play senior housing real estate investment trust (REIT), announced results fo r the quarter ended

$GEVLow

Here are Wednesday's biggest analyst calls: Nvidia, Tesla, Netflix, Broadcom, Micron, Lyft, AMD, Figma & more

Wall Street analysts issued a range of calls on Wednesday. Bernstein initiated GE Vernova (outperform), NeoVolta (buy, $8 PT) and reiterated Nvidia (outperform). Deutsche Bank raised Micron’s PT to $1,500 ahead of next week’s earnings. Bernstein also lifted AMD to $600, Intel to $100, and Arm to $500. Morgan Stanley downgraded ResMed to equal weight; Citi initiated Figma (buy, $36 PT).

Related tickers